The Cordis medical device business that Cardinal Health bought for $1.9 billion is proving to be a millstone for the company. Cordis, a former Johnson & Johnson subsidiary, ran into a raft of difficulties in the third quarter (PDF)...
China Food and Drug Administration (CFDA) consecutively issued four reform policies (drafts for comment) on May 11 to solicit public opinions from the society.